Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Nio Stock May Rebound After the Latest Slump

By Chris Lau, InvestorPlace Contributor

Investors are too negative on Nio stock as the company's prospects grow with the ET7 launch, global expansion and a path to profitability.

Disappointed DocuSign Investors Watching for Signs of Post-pandemic Future

By Chris Lau, InvestorPlace Contributor

Investors did not like DocuSign’s outlook, punishing DOCU stock for headwinds when customer digitization will lift long-term revenue.

Why The Federal Reserve’s Rate Hike Matters for SOFI stock, For Now

By Chris Lau, InvestorPlace Contributor

Sofi’s stock drop in the last month created an attractive entry point for investors seeking a long-term growth holding in the fintech space.

Why Intel Stock Will Rise Further Going Forward

By Chris Lau, InvestorPlace Contributor

Intel’s upcoming discrete graphics card, its Mobileye spin off, and Intel's new, well-received CPU will help boost INTC stock.

Why Roblox Will Rise in 2022

By Chris Lau, InvestorPlace Contributor

Roblox’s brand is getting stronger, as momentum from monthly active users grows during the strong holiday period to support RBLX stock.

Load More